Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Ductal Histologic Type”

709 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 709 results

Not applicableStudy completedNCT02592356
What this trial is testing

Effect of Cabozantinib S-Malate or Lenvatinib Mesylate on Weight and Body Composition in Patients With Metastatic Endocrine Cancer

Who this might be right for
Differentiated Thyroid Gland CarcinomaMalignant Adrenal Gland PheochromocytomaMalignant Paraganglioma+1 more
M.D. Anderson Cancer Center 23
Early research (Phase 1)Study completedNCT01009437
What this trial is testing

Ritonavir and Its Effects on Biomarkers in Women Undergoing Surgery for Newly Diagnosed Breast Cancer

Who this might be right for
Breast Cancer
Masonic Cancer Center, University of Minnesota 28
Early research (Phase 1)Study completedNCT04990037
What this trial is testing

The Safety and Tolerance of CAN04 in Combination With FOLFIRINOX in Subjects With Metastatic Pancreatic Ductal Adenocarcinoma

Who this might be right for
Metastatic Pancreatic Ductal Adenocarcinoma
Cantargia AB 25
Not applicableUnknownNCT03435770
What this trial is testing

Evaluation of Safety and Feasibility of EUS-guided RFA for Solid Pancreatic Neoplasms

Who this might be right for
Pancreatic CancerPancreatic NeoplasmsPancreatic Adenocarcinoma+2 more
Singapore General Hospital 10
Not applicableStudy completedNCT00897208
What this trial is testing

Studying Biomarkers in Nipple Fluid, Urine, and Blood Samples From Women With Newly Diagnosed Ductal Carcinoma In Situ or Stage I or Stage II Breast Cancer and in Women at Risk of Developing Breast Cancer

Who this might be right for
Breast Cancer
Mayo Clinic 316
Not applicableActive Not RecruitingNCT04970134
What this trial is testing

Spanish Study for Molecular Characterization of Thyroid Carcinoma

Who this might be right for
Differentiated Thyroid CarcinomaMedullary Thyroid Carcinoma
Grupo Español de Tratamiento de Tumores de Cabeza y Cuello 150
Not applicableUnknownNCT00470236
What this trial is testing

Radiation Doses and Fractionation Schedules in Non-low Risk Ductal Carcinoma In Situ (DCIS) of the Breast

Who this might be right for
Carcinoma, Ductal, Breast
Trans Tasman Radiation Oncology Group 1,608
Early research (Phase 1)Ended earlyNCT03525392
What this trial is testing

Study to Evaluate the Safety and Activity (Including Distribution) of 177Lu-3BP-227 in Subjects With Solid Tumours Expressing Neurotensin Receptor Type 1.

Who this might be right for
Pancreatic Ductal AdenocarcinomaColorectal CancerGastric Cancer+5 more
Ipsen 14
Testing effectiveness (Phase 2)Enrolling By InvitationNCT06843681
What this trial is testing

Trastuzumab Plus Taxane Neoadjuvant Therapy for HER2-Positive Breast Ductal Carcinoma In Situ (DCIS) : A Phase II Study

Who this might be right for
Breast Carcinoma in Situ
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 54
Testing effectiveness (Phase 2)Ended earlyNCT04779151
What this trial is testing

Basket Trial Exploring the Efficacy and Safety of the Combination of Niraparib and Dostarlimab

Who this might be right for
Urothelial Bladder CancerGastric AdenocarcinomaGastro-oesophageal Adenocarcinoma+5 more
Gustave Roussy, Cancer Campus, Grand Paris 51
Large-scale testing (Phase 3)Study completedNCT00003857
What this trial is testing

Radiation Therapy With or Without Optional Tamoxifen in Treating Women With Ductal Carcinoma in Situ

Who this might be right for
Breast Cancer
Radiation Therapy Oncology Group 636
Not applicableLooking for participantsNCT06574373
What this trial is testing

Identification of New Theranostic Biomarkers of Pancreatic Tumor Progression

Who this might be right for
IPMN, Pancreatic
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 3,600
Early research (Phase 1)Study completedNCT02658214
What this trial is testing

Durvalumab and Tremelimumab in Combination With First-Line Chemotherapy in Advanced Solid Tumors

Who this might be right for
Small Cell Lung CarcinomaCarcinoma, Squamous Cell of Head and NeckStomach Neoplasms+7 more
AstraZeneca 32
Testing effectiveness (Phase 2)UnknownNCT01641406
What this trial is testing

"Phase II Study of PET Guided Neoadjuvant Chemotherapy (NAC) and Oncotype Guided Hormonal Therapy of Breast Cancer"

Who this might be right for
Infiltrating Duct and Lobular Carcinoma In SituInvasive Lobular Breast CarcinomaInflammatory Breast Carcinoma
Auxilio Mutuo Cancer Center 60
Not applicableStudy completedNCT02216136
What this trial is testing

Tumor: Breast Ratio Study

Who this might be right for
Breast CancerLCISDCIS
Washington University School of Medicine 162
Not applicableStudy completedNCT06243965
What this trial is testing

Is Desmoplastic Stromal Reaction Useful to Modulate Lymph Node Dissection in Sporadic Medullary Thyroid Carcinoma?

Who this might be right for
Medullary Thyroid CancerMedullary CarcinomaMedullary Tumor+6 more
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 246
Not applicableStudy completedNCT02933307
What this trial is testing

Continuous Monitoring on the General Ward

Who this might be right for
Carcinoma, Pancreatic DuctalColorectal NeoplasmsArthritis+2 more
Radboud University Medical Center 90
Not applicableLooking for participantsNCT04985032
What this trial is testing

Accelerated Partial Breast Irradiation (APBI) Using Stereotactic Body Radiation Therapy (SBRT)

Who this might be right for
Ductal Carcinoma in SituInvasive Ductal Carcinoma of Female Breast
RPCR, Inc. 200
Not applicableLooking for participantsNCT03448926
What this trial is testing

The PREDICT Registry:

Who this might be right for
DCIS
PreludeDx 3,000
Not applicableStudy completedNCT05534594
What this trial is testing

Evaluation of the 18F-PSMA Positron Emission Tomography (PET)/CT in Patients With Medullary Thyroid Cancer

Who this might be right for
Medullary Thyroid CancerMedullary Thyroid CarcinomaThyroid Carcinoma, Medullary+1 more
University Medical Center Groningen 8
Load More Results